Draper Therapies Happy to Announce U.S. FDA Determines Celliant® Responsive Textile Products Meet Criteria as Medical Devices and General Wellness ProductsBecky Shipps
July 27, 2017, Canton, MA – Draper Therapies is thrilled to announce that the United States Food and Drug Administration has determined that products containing Celliant® meet the criteria for medical devices and general wellness products and will be categorized as such. All of Draper Therapies’ products contain Celliant, a smart fiber clinically proven to:
- Temporarily increases local circulation
- Increases cellular oxygenation
- Increases tissue oxygen levels
- Enhances/increases performance
- Increases/more energy
- Increases/more/better endurance
- Increases/enhances/more speed
- Improves/increases strength
- Increases/more stamina
- Faster/quicker recovery
- Promotes restful sleep
- Helps increase comfort
- Recycles human energy
“I think this is incredibly important because it will encourage folks to try our products and generate interest in responsive textiles in general.” says Draper Therapies product manager Becky Shipps. “I am excited for the future of both Draper Therapies and Celliant!”
To shop the Draper Therapies product line, click here.
To read more about Celliant, click here.
To read the full press release from PR News Wire, click here.